High-mobility group box 1 and the receptor for advanced glycation end products contribute to lung injury during Staphylococcus aureus pneumonia

Critical Care

Volumn 17, Issue 6, 2013, Pages

  Achouiti, Ahmed ^a,b   van der Meer, Anne J ^a,b   Florquin, Sandrine ^b   Yang, Huan ^c   Tracey, Kevin J ^c   van 't Veer, Cornelis ^a,b   de Vos, Alex F ^a,b   van der Poll, Tom ^a,b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1BETA; LIPOPROTEIN RECEPTOR; MONOCLONAL ANTIBODY; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; CHEMOKINE; CYTOKINE; IMMUNOGLOBULIN RECEPTOR; TOLL LIKE RECEPTOR 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; CONTROLLED STUDY; LUNG INJURY; LUNG LAVAGE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; STAPHYLOCOCCAL PNEUMONIA; STAPHYLOCOCCUS AUREUS; WILD TYPE; ANIMAL; CHEMISTRY; DISEASE MODEL; LUNG; METABOLISM; NEUTROPHIL; PATHOLOGY;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINES; CYTOKINES; DISEASE MODELS, ANIMAL; GLYCOSYLATION END PRODUCTS, ADVANCED; HMGB1 PROTEIN; LUNG; MICE; NEUTROPHILS; PNEUMONIA, STAPHYLOCOCCAL; RECEPTORS, IMMUNOLOGIC; TOLL-LIKE RECEPTOR 4;

EID: 84890278740     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13162     Document Type: Article

References (29)

1. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998, 339:520-532. 10.1056/NEJM199808203390806, 9709046.
2. Boucher HW, Corey GR. Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis Official Pub Infect Dis Soc Am 2008, 46:S344-S349.
3. Francis JS, Doherty MC, Lopatin U, Johnston CP, Sinha G, Ross T, Cai M, Hansel NN, Perl T, Ticehurst JR, Carroll K, Thomas DL, Nuermberger E, Bartlett JG. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis Official Pub Infect Dis Soc Am 2005, 40:100-107.
4. Parker D, Prince A. Immunopathogenesis of Staphylococcus aureus pulmonary infection. Seminars Immunopathol 2012, 34:281-297.
5. Bartlett AH, Foster TJ, Hayashida A, Park PW. Alpha-toxin facilitates the generation of CXC chemokine gradients and stimulates neutrophil homing in Staphylococcus aureus pneumonia. J Infect Dis 2008, 198:1529-1535. 10.1086/592758, 18823272.
6. Craig A, Mai J, Cai S, Jeyaseelan S. Neutrophil recruitment to the lungs during bacterial pneumonia. Infect Immunity 2009, 77:568-575.
7. Diep BA, Chan L, Tattevin P, Kajikawa O, Martin TR, Basuino L, Mai TT, Marbach H, Braughton KR, Whitney AR, Gardner DJ, Fan X, Tseng CW, Liu GY, Badiou C, Etienne J, Lina G, Matthay MA, DeLeo FR, Chambers HF. Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. Proc Natl Acad Sci USA 2010, 107:5587-5592. 10.1073/pnas.0912403107, 2851770, 20231457.
8. Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukocyte Biol 2007, 81:1-5.
9. Sims GP, Rowe DC, Rietdijk ST, Herbst R, Coyle AJ. HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 2010, 28:367-388. 10.1146/annurev.immunol.021908.132603, 20192808.
10. Yang H, Antoine DJ, Andersson U, Tracey KJ. The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis. J Leukocyte Biol 2013, 93:865-873. 10.1189/jlb.1212662, 23446148.
11. Constien R, Forde A, Liliensiek B, Grone HJ, Nawroth P, Hammerling G, Arnold B. Characterization of a novel EGFP reporter mouse to monitor Cre recombination as demonstrated by a Tie2 Cre mouse line. Genesis 2001, 30:36-44. 10.1002/gene.1030, 11353516.
12. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 1999, 162:3749-3752.
13. Entezari M, Weiss DJ, Sitapara R, Whittaker L, Wargo MJ, Li J, Wang H, Yang H, Sharma L, Phan BD, Javdan M, Chavan SS, Miller EJ, Tracey KJ, Mantell LL. Inhibition of high-mobility group box 1 protein (HMGB1) enhances bacterial clearance and protects against Pseudomonas Aeruginosa pneumonia in cystic fibrosis. Mole Med 2012, 18:477-485.
14. Rijneveld AW, Weijer S, Florquin S, Esmon CT, Meijers JC, Speelman P, Reitsma PH, Ten Cate H, van der Poll T. Thrombomodulin mutant mice with a strongly reduced capacity to generate activated protein C have an unaltered pulmonary immune response to respiratory pathogens and lipopolysaccharide. Blood 2004, 103:1702-1709. 10.1182/blood-2002-05-1380, 14592828.
15. Patel VS, Sitapara RA, Gore A, Phan B, Sharma L, Sampat V, Li JH, Yang H, Chavan SS, Wang H, Tracey KJ, Mantell LL. High mobility group box-1 mediates hyperoxia-Induced Impairment of pseudomonas aeruginosa clearance and inflammatory lung injury in mice. Am J Respiratory Cell Mole Biol 2013, 48:280-287.
16. Abraham E, Arcaroli J, Carmody A, Wang H, Tracey KJ. HMG-1 as a mediator of acute lung inflammation. J Immunol 2000, 165:2950-2954.
17. Kim JY, Park JS, Strassheim D, Douglas I, Diaz del Valle F, Asehnoune K, Mitra S, Kwak SH, Yamada S, Maruyama I, Ishizaka A, Abraham E. HMGB1 contributes to the development of acute lung injury after hemorrhage. Am J Physiol Lung Cell Mole Physiol 2005, 288:L958-L965.
18. Ogawa EN, Ishizaka A, Tasaka S, Koh H, Ueno H, Amaya F, Ebina M, Yamada S, Funakoshi Y, Soejima J, Moriyama K, Kotani T, Hashimoto S, Morisaki H, Abraham E, Takeda J. Contribution of high-mobility group box-1 to the development of ventilator-induced lung injury. Am J Respir Crit care Med 2006, 174:400-407. 10.1164/rccm.200605-699OC, 16728713.
19. Schierbeck H, Lundback P, Palmblad K, Klevenvall L, Erlandsson-Harris H, Andersson U, Ottosson L. Monoclonal anti-HMGB1 (high mobility group box chromosomal protein 1) antibody protection in two experimental arthritis models. Mole Med 2011, 17:1039-1044.
20. Sethi S, Chakraborty T. Role of TLR-/NLR-signaling and the associated cytokines involved in recruitment of neutrophils in murine models of Staphylococcus aureus infection. Virulence 2011, 2:316-328. 10.4161/viru.2.4.16142, 21758006.
21. van Zoelen MA, Yang H, Florquin S, Meijers JC, Akira S, Arnold B, Nawroth PP, Bierhaus A, Tracey KJ, van der Poll T. Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo. Shock 2009, 31:280-284. 10.1097/SHK.0b013e318186262d, 19218854.
22. Kuipers MT, van der Poll T, Schultz MJ, Wieland CW. Bench-to-bedside review: Damage-associated molecular patterns in the onset of ventilator-induced lung injury. Crit Care 2011, 15:235. 10.1186/cc10437, 3388678, 22216838.
23. Tsung A, Klune JR, Zhang X, Jeyabalan G, Cao Z, Peng X, Stolz DB, Geller DA, Rosengart MR, Billiar TR. HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J Exp Med 2007, 204:2913-2923. 10.1084/jem.20070247, 2118528, 17984303.
24. Levy RM, Mollen KP, Prince JM, Kaczorowski DJ, Vallabhaneni R, Liu S, Tracey KJ, Lotze MT, Hackam DJ, Fink MP, Vodovotz Y, Billiar TR. Systemic inflammation and remote organ injury following trauma require HMGB1. Am J Physiol Regulatory Integr Compar Physiol 2007, 293:R1538-R1544.
25. Zhang X, Shan P, Qureshi S, Homer R, Medzhitov R, Noble PW, Lee PJ. Cutting edge: TLR4 deficiency confers susceptibility to lethal oxidant lung injury. J Immunol 2005, 175:4834-4838.
26. Ogawa Y, Tasaka S, Yamada W, Saito F, Hasegawa N, Miyasho T, Ishizaka A. Role of Toll-like receptor 4 in hyperoxia-induced lung inflammation in mice. Inflam Res Official J Euro Histamine Res Soc 2007, 56:334-338.
27. Reynolds PR, Schmitt RE, Kasteler SD, Sturrock A, Sanders K, Bierhaus A, Nawroth PP, Paine R, Hoidal JR. Receptors for advanced glycation end-products targeting protect against hyperoxia-induced lung injury in mice. Am J Respir Cell Mole Biol 2010, 42:545-551.
28. He M, Kubo H, Ishizawa K, Hegab AE, Yamamoto Y, Yamamoto H, Yamaya M. The role of the receptor for advanced glycation end-products in lung fibrosis. Am J Physiol Lung Cell Mole Physiol 2007, 293:L1427-L1436.
29. van Zoelen MA, Schouten M, de Vos AF, Florquin S, Meijers JC, Nawroth PP, Bierhaus A, van der Poll T. The receptor for advanced glycation end products impairs host defense in pneumococcal pneumonia. J Immunol 2009, 182:4349-4356. 10.4049/jimmunol.0801199, 19299735.